company background image
2309 logo

CMIC HOLDINGS TSE:2309 Stock Report

Last Price

JP¥2.64k

Market Cap

JP¥44.7b

7D

0.2%

1Y

26.6%

Updated

01 Apr, 2024

Data

Company Financials

CMIC HOLDINGS Co., Ltd.

TSE:2309 Stock Report

Market Cap: JP¥44.7b

2309 Stock Overview

CMIC HOLDINGS Co., Ltd. provides pharmaceutical development services in Japan.

2309 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends4/6

CMIC HOLDINGS Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CMIC HOLDINGS
Historical stock prices
Current Share PriceJP¥2,644.00
52 Week HighJP¥2,657.00
52 Week LowJP¥1,616.00
Beta0.56
11 Month Change0.11%
3 Month Change0.076%
1 Year Change26.57%
33 Year Change69.81%
5 Year Change70.69%
Change since IPO76.27%

Recent News & Updates

Recent updates

Shareholder Returns

2309JP Life SciencesJP Market
7D0.2%1.7%-1.2%
1Y26.6%-33.8%23.4%

Return vs Industry: 2309 exceeded the JP Life Sciences industry which returned -28.6% over the past year.

Return vs Market: 2309 underperformed the JP Market which returned 35.7% over the past year.

Price Volatility

Is 2309's price volatile compared to industry and market?
2309 volatility
2309 Average Weekly Movement0.3%
Life Sciences Industry Average Movement5.1%
Market Average Movement3.7%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.8%

Stable Share Price: 2309 has not had significant price volatility in the past 3 months.

Volatility Over Time: 2309's weekly volatility has decreased from 6% to 0% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19854,684Kazuo Nakamurawww.cmicgroup.com

CMIC HOLDINGS Co., Ltd. provides pharmaceutical development services in Japan. The company offers clinical trial services, including audit and quality assurance, clinical operations and trials, data management, clinical caretaker, patient recruitment, pharmacovigilance, project management, and statistical analysis; and clinical site network, CMC, drug development, health economics and outcome research, market entry/out-licensing, medical devices and in vitro diagnostic consulting, medical writing, national health insurance/drug pricing, and product life cycle management consulting services. It also provides development and manufacturing services, including commercial supply, contract development and manufacturing, investigational product manufacturing, packaging and labeling, release and stability tests, and technology transfer, as well as formulation development services; and laboratory services, such as bioanalysis and GLP analysis, biomarkers, CMC and GMP analysis, large molecule, oligonucleotides, small molecule, and toxicity, as well as efficacy and safety pharmacology, in vitro and in vivo, and non-clinical studies.

CMIC HOLDINGS Co., Ltd. Fundamentals Summary

How do CMIC HOLDINGS's earnings and revenue compare to its market cap?
2309 fundamental statistics
Market capJP¥44.69b
Earnings (TTM)JP¥5.33b
Revenue (TTM)JP¥93.11b

8.4x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2309 income statement (TTM)
RevenueJP¥93.11b
Cost of RevenueJP¥72.30b
Gross ProfitJP¥20.81b
Other ExpensesJP¥15.48b
EarningsJP¥5.33b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)315.19
Gross Margin22.35%
Net Profit Margin5.72%
Debt/Equity Ratio7.1%

How did 2309 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

13%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.